CAS: 2349386-89-4
尿苷,4-肟,5'-(2-甲基丙酸酯)
CAS:2349386-89-4
Formula:
C13H19N3O7
Purity:
98%
Color and Shape:
Solid
Molecular weight:
329.3059
Ref: IN-DA01JNIM
1g | 66.00 € | ||
5g | 82.00 € | ||
25g | 165.00 € | ||
100g | 617.00 € | ||
10mg | 27.00 € | ||
500g | To inquire | ||
50mg | 37.00 € | ||
100mg | 48.00 € | ||
250mg | 48.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-M-247001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
EIDD-2801
CAS:2349386-89-4
EIDD-2801 (Molnupiravir) is a prodrug for N 4-hydroxycytidine, effective against influenza and various coronaviruses.
Formula:
C13H19N3O7
Purity:
100% - 99.70%
Color and Shape:
Solid
Molecular weight:
329.31
Ref: TM-T8309
1g | 646.00 € | ||
5mg | 40.00 € | ||
10mg | 60.00 € | ||
25mg | 78.00 € | ||
50mg | 118.00 € | ||
100mg | 184.00 € | ||
200mg | 345.00 € | ||
500mg | 441.00 € | ||
1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
EIDD 2801-D7
Controlled ProductCAS:2349386-89-4
Formula:
C13D7H12N3O7
Color and Shape:
Neat
Molecular weight:
336.35
Ref: TR-E985797
1mg | 268.00 € | ||
5mg | 1,158.00 € | ||
10mg | 1,809.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Molnupiravir - Bio-X ™
CAS:2349386-89-4
EIDD 2801 is an orally bioavailable prodrug of β-D-N4-hydroxycytidine and was shown to inhibit SARS-CoV-2 …
Formula:
C13H19N3O7
Purity:
Min. 95%
Color and Shape:
Clear Liquid
Molecular weight:
329.31 g/mol
Ref: 3D-BM300002
5mg | 136.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Molnupiravir
CAS:2349386-89-4
EIDD 2801 is an orally bioavailable prodrug of β-D-N4-hydroxycytidine and was shown to inhibit SARS-CoV-2 …
Formula:
C13H19N3O7
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
329.31 g/mol
Ref: 3D-AE176721
10mg | 181.00 € | ||
25mg | 221.00 € | ||
50mg | 341.00 € | ||
100mg | 512.00 € | ||
250mg | 1,017.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025